HIV-ASSOCIATED LIPODYSTROPHY AND LIPOATROPHY

RV Sekhar - Fundamentals of HIV Medicine 2021, 2021 - books.google.com
“Lipodystrophy” is a broad term that collectively describes a variable combination of
accumulation of fat in several regions, including the abdomen (Engelson et al., 1999; Miller …

[引用][C] HIV-associated lipodystrophy: pathogenesis and clinical features

G Barbaro - HIV Infection and the Cardiovascular System, 2003 - karger.com
HIV-associated lipodystrophy, first described in 1998 [1], is characterized by peripheral
lipoatrophy of the face, limbs and buttocks, and central fat accumulation within the abdomen …

HIV facial lipoatrophy: etiology and methods of correction

DH Jones - BASIC AND CLINICAL DERMATOLOGY, 2006 - api.taylorfrancis.com
HIV-associated lipodystrophy is an as yet undefined syndrome that may include
hypertriglyceridemia, insulin resistance, diabetes, dorsocervical fat accumulation (buffalo …

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

A Carr - The Lancet, 2003 - thelancet.com
Background Lipodystrophy (peripheral lipoatrophy, central fat accumulation, and
lipomatosis) is a common and disfiguring problem in adult patients with HIV-1 infection on …

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia

J Miller, A Carr, S Emery, M Law, S Mallal… - HIV …, 2003 - Wiley Online Library
Objective To establish the prevalence, severity and factors associated with the HIV
lipodystrophy syndrome. Methods Cross‐sectional study of lipodystrophy conducted in high …

HIV-associated lipodystrophy syndrome

S Mauss - AIDS, 2000 - journals.lww.com
HIV-associated lipodystrophy syndrome, also known as fat redistribution syndrome, is an
only recently described disorder consisting of changes in body fat distribution, metabolic …

[HTML][HTML] HIV-associated Lipodystrophy

N Guzman, V Vijayan - StatPearls [Internet], 2022 - ncbi.nlm.nih.gov
Objectives: Identify the etiology of HIV-associated lipodystrophy. Describe the typical
physical exam of a patient with HIV-associated lipoatrophy. Review the treatment and …

Clinical perspectives on HIV-associated lipodystrophy syndrome: an update

A Shevitz, CA Wanke, J Falutz, DP Kotler - Aids, 2001 - journals.lww.com
In developed countries, the availability of highly active antiretroviral therapy (HAART) has
contributed to a dramatic decrease in mortality and opportunistic infections associated with …

[PDF][PDF] HIV lipodystrophy: where are we after ten years

N Vergel - GMHC Treat Issues, 2007 - medibolics.com
Ten years have passed since the first report of lipodystrophy at an HIV conference. The
excitement and hope for a longer life that accompanied the arrival of Highly Active Anti …

HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management

A Carr - Aids, 2003 - journals.lww.com
HIV lipodystrophy is a heterogeneous syndrome, which has yet to be objectively defined,
comprising peripheral lipoatrophy, central fat accumulation and lipomata, along with …